Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

Laboratory Testing Supplies for Hologic Analyzers for the Landstuhl Regional Medical Center, Germany

Awarded
W9114F26DA003Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → W40M Mrco EuropeView Agency

Contract Value

$1,520,640.46

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

Landstuhl, DE-RP, 66849, DEU

Set-Aside

NONE

Awardee

MEDITRADE MEDICAL TRADING GMBHView Profile

Award Issued Date

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → W40M Mrco Europe
Contacts2 people available
OfficeAPO, AE, 09180-0402, USA
Organization / Agency
Department Of Defense → W40M Mrco Europe
View Agency Profile
Office AddressAPO, AE, 09180-0402, USA
Contacts
Henning Mayer-Goldstein
Matthew R. Elden

Full Description

Show more
https://api.sam.gov/prod/opportunities/v1/noticedesc?noticeid=700ee1debcbe48629073e288f57ed822

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → W40M Mrco Europe

Same awarding agency

NAICS: 325413
Federal
Blood Chemistry Testing - Cost Per Reportable Result
Solicitation # W9114F-26-Q-A009
The Medical Readiness Contracting Office-Europe plans to award a Fixed-Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to provide an automated clinical chemistry analyzer system, including all necessary equipment, reagents, consumables, controls, and maintenance services, to support hematology testing at the U.S. Army Health Clinic in Vicenza, Italy. This contract will operate under a Cost Per Reportable Result (CPRR) contract line item number structure, covering a two-month phase-in period from January 2 through February 28, 2026, followed by a main ordering period extending from March 1, 2026, to December 31, 2030. The solicitation is aligned with NAICS code 324513 (In-Vitro Diagnostic Substance Manufacturing) and applies a Lowest Price Technically Acceptable (LPTA) evaluation process under Simplified Acquisition Procedures with full and open competition. Vendors are required to be registered in the System for Award Management (SAM) prior to quote submission, with the Request for Quotes (RFQ) expected to be posted around November 5, 2025. The contract scope entails delivering a fully integrated, FDA-approved random-access chemistry analyzer capable of handling diverse specimen types with automated barcode reading compliant with CLSI standards. The system must reliably support the estimated annual workload of over 42,000 clinical chemistry tests, providing timely results with minimal downtime through features such as uninterrupted power supply and water system integration. The contractor is responsible for supply chain management of reagents and consumables, maintaining quality control consistency with limited annual lot changes, and meeting rigorous inspection criteria at government acceptance sites, including shelf life and storage temperature standards. Compliance with federal and DoD cybersecurity, privacy laws (including HIPAA), RMF authorizations, and data breach reporting protocols is mandatory, with annual privacy training required for personnel. Although specific contract clauses, detailed pricing, and submission instructions are forthcoming with the RFQ, the contract emphasizes operational continuity, regulatory compliance, and strict quality standards essential to laboratory mission readiness at the Vicenza facility.
In-Vitro Diagnostic Substance Manufacturing

POSTED

10 months ago

DEADLINE

N/A
View Details